Literature DB >> 10093988

Genetic variation of CYP2A6, smoking, and risk of cancer.

S J London, J R Idle, A K Daly, G A Coetzee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10093988     DOI： 10.1016/S0140-6736(98)04984-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  20 in total

Review 1.  Genetic risk and behavioural change.

Authors:  T M Marteau; C Lerman
Journal:  BMJ       Date:  2001-04-28

Review 2.  Polymorphisms of CYP2A6 and its practical consequences.

Authors:  H Raunio; A Rautio; H Gullstén; O Pelkonen
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

Review 3.  Candidate gene case-control association studies: advantages and potential pitfalls.

Authors:  A K Daly; C P Day
Journal:  Br J Clin Pharmacol       Date:  2001-11       Impact factor: 4.335

4.  Catalog of 680 variations among eight cytochrome p450 ( CYP) genes, nine esterase genes, and two other genes in the Japanese population.

Authors:  Susumu Saito; Aritoshi Iida; Akihiro Sekine; Saori Kawauchi; Shoko Higuchi; Chie Ogawa; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2003-04-29       Impact factor: 3.172

5.  Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of lung cancer.

Authors:  Chikako Kiyohara; Taro Shirakawa; Julian M Hopkin
Journal:  Environ Health Prev Med       Date:  2002-05       Impact factor: 3.674

6.  Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk.

Authors:  Yesha M Patel; Sunghim L Park; Younghun Han; Lynne R Wilkens; Heike Bickeböller; Albert Rosenberger; Neil Caporaso; Maria Teresa Landi; Irene Brüske; Angela Risch; Yongyue Wei; David C Christiani; Paul Brennan; Richard Houlston; James McKay; John McLaughlin; Rayjean Hung; Sharon Murphy; Daniel O Stram; Christopher Amos; Loïc Le Marchand
Journal:  Cancer Res       Date:  2016-08-03       Impact factor: 12.701

7.  Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.

Authors:  Andrew A Strasser; Neal L Benowitz; Angela G Pinto; Kathy Z Tang; Stephen S Hecht; Steve G Carmella; Rachel F Tyndale; Caryn E Lerman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-01-06       Impact factor: 4.254

8.  Phenotypic CYP2A6 variation and the risk of pancreatic cancer.

Authors:  Susan Kadlubar; Jeffrey P Anderson; Carol Sweeney; Myron D Gross; Nicholas P Lang; Fred F Kadlubar; Kristin E Anderson
Journal:  JOP       Date:  2009-05-18

Review 9.  Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction.

Authors:  Yann S Mineur; Marina R Picciotto
Journal:  Biochem Pharmacol       Date:  2007-06-14       Impact factor: 5.858

10.  Nicotine metabolism in three ethnic/racial groups with different risks of lung cancer.

Authors:  Kiersten S Derby; Kristine Cuthrell; Christian Caberto; Steven G Carmella; Adrian A Franke; Stephen S Hecht; Sharon E Murphy; Loïc Le Marchand
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11-24       Impact factor: 4.254
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.